The efficacy of immunotherapy in non-small cell lung cancer with KRAS mutation: a systematic review and meta-analysis by Rui Zhao, Yang Shu, Wei Xu, Fengxian Jiang, Pancen Ran, Liying Pan, Jingliang Wang, Weihao Wang, Jing Zhao, Yahui Wang, Guobin Fu

Subjects: “…KRAS mutation…”
Get full text

Elevated KRAS protein level is associated with better survival in pancreatic cancer by S. M. Stålberg, L. Silwal-Pandit, J. Hamfjord, D. J. H. Nebdal, J. Lehtiö, O. C. Lingjærde, B. S. Skålhegg, E. H. Kure

Subjects: Get full text

Drugging the ‘undruggable’ KRAS: breakthroughs, challenges, and opportunities in pancreatic cancer by Nawaz Khan, Umar Raza, Syed Aqib Ali Zaidi, Muhadaisi Nuer, Kayisaier Abudurousuli, Yipaerguli Paerhati, Alifeiye Aikebaier, Wenting Zhou

Subjects: Get full text

Targeting KRAS: from metabolic regulation to cancer treatment by Yanyan Shi, Huiling Zheng, Tianzhen Wang, Shengpu Zhou, Shiqing Zhao, Mo Li, Baoshan Cao

Subjects: “…KRAS-driven cancers…”
Get full text

KRAS4B is required for placental development by Marie-Albane Minati, Leyre López Muneta, Younes Achouri, Sophie Pirenne, Corentin Porada, Francesca Rochais, Patrick Jacquemin

Subjects: “…KRAS4A…”
Get full text

A Phase 1/1B Trial of Pembrolizumab and Trametinib in Advanced NSCLC Enriched for KRAS Mutations by Jonathan W. Riess, MD, MS, Matthew S. Lara, BS, Guillaume Luxardi, PhD, Miguel Lopez de Rodas, MD, Michiko Shimoda, PhD, Karen Kelly, MD, Primo N. Lara, MD, Laurel Beckett, PhD, Arta Monjazeb, MD, PhD, Kurt A. Schalper, MD, PhD, Emanual Maverakis, MD, David R. Gandara, MD

Subjects: Get full text

Development of PD3 and PD3-B for PDEδ inhibition to modulate KRAS activity by Jungeun Lee, Ho Jin Lee, Yeongcheol Lee, Bumhee Lim, Jongsik Gam, Dong-Chan Oh, Jeeyeon Lee

Subjects: “…KRAS…”
Get full text

Editorial: KRAS in stage IV non-small cell lung cancer by Anneloes L. Noordhof, Torsten Gerriet Blum, Torsten Gerriet Blum, Georgia Hardavella, Lizza E. L. Hendriks, Wouter H. van Geffen

Subjects: Get full text

Targeting the HER2-ELF3-KRAS axis: a novel therapeutic strategy for KRASG13D colorectal cancer by Soo-Yeon Hwang, Yoojeong Seo, Seojeong Park, Seul-Ah Kim, Inhye Moon, Yi Liu, Seojeong Kim, Eun Seon Pak, Sehyun Jung, Hyeyoon Kim, Kyung-Hwa Jeon, Seung Hee Seo, Inyoung Sung, Heetak Lee, So-Yeon Park, Younghwa Na, Tae Il Kim, Youngjoo Kwon

Subjects: Get full text

KRAS-mutated non-small cell lung cancer: new therapy strategies by K. K. Laktionov, K. A. Sarantseva, L. A. Nelyubina, S. V. Gamayunov, E. A. Kolesnikova, M. G. Gordiev

Subjects: Get full text

Combination of farnesyl-transferase inhibition with KRAS G12D targeting breaks down therapeutic resistance in pancreatic cancer by Eszter Molnár, Marcell Baranyi, Marcell Baranyi, Krisztina Szigeti, Luca Hegedűs, Fanni Bordás, Zsófia Gábriel, Gréta Petényi, József Tóvári, Balázs Hegedűs, Balázs Hegedűs, József Tímár

Subjects: Get full text

Jorunnamycin A induces apoptosis in pancreatic ductal adenocarcinoma cells, spheroids, and patient-derived organoids by modulating KRAS-mediated survival pathways by Hnin Ei Ei Khine, Utid Suriya, Thanyada Rungrotmongkol, Supakarn Chamni, Yanxi Lu, Alan Bénard, Bin Lan, Debabrata Mukhopadhyay, David Chang, Andrew Biankin, Regine Schneider-Stock, Robert Grützmann, Rungroch Sungthong, Christian Pilarsky, Chatchai Chaotham

Subjects: Get full text

RASGRF1在结直肠癌组织中高表达对肿瘤转移和不良预后的影响

Subjects: Get full text

Acetylation-induced degradation of ECHS1 enhances BCAA accumulation and proliferation in KRAS-mutant colorectal cancer by Zhenkang Li, Zhengyu Liu, Mingdao Lin, Huayang Pan, Yuechen Liu, Yang Liu, Yuwen Xie, Jinchao Zhang, Shenyuan Guan, Yongsheng Li, Mulan Zhu, Yuan Fang, Zhiyong Shen, Haijun Deng

Subjects: Get full text

Mapping the Interactome of KRAS and Its G12C/D/V Mutants by Integrating TurboID Proximity Labeling with Quantitative Proteomics by Jiangwei Song, Busong Wang, Mingjie Zou, Haiyuan Zhou, Yibing Ding, Wei Ren, Lei Fang, Jingzi Zhang

Subjects: “…KRAS interactome…”
Get full text

The role of KRAS and NRAS mutation detection in determining the therapy strategy for colorectal cancer by A. N. Toropovskiy, A. G. Nikitin, D. A. Viktorov, A. V. Solov'ev, R. M. Khuzina, O. N. Pavlova

Subjects: Get full text

Precision immune regulation in KRAS-mutated cancers: the final piece of the puzzle? by Shenao Fu, Jiayao Ma, Changjing Cai, Jun Tan, Xiangying Deng, Hong Shen, Shan Zeng, Yihong Chen, Ying Han

Subjects: “…KRAS…”
Get full text

Examining the Outcomes of Palliative Oophorectomy of Ovarian Metastases in de-Novo Metastatic Colorectal Cancer and Its Association with RAS Mutation Status: Insights from a Single... by Alawabdeh T, Al-Ya’goub MI, Hamo K, Almasri Y, Turfa R, Alnassarwin S, Masadeh HI, Khader R, Mubaydeen T

Subjects: Get full text

KRAS as a predictor of poor prognosis and benefit from postoperative FOLFOX chemotherapy in patients with stage II and III colorectal cancer by Yanhong Deng, Li Wang, Shuyun Tan, George P. Kim, Ruoxu Dou, Dianke Chen, Yue Cai, Xinhui Fu, Lei Wang, Jun Zhu, Jianping Wang

Subjects: “…KRAS…”
Get full text

Mechanistic Foundations of KRAS‐Driven Tumor Ecosystems: Integrating Crosstalk among Immune, Metabolic, Microbial, and Stromal Microenvironment by Jiayao Ma, Shenao Fu, Jun Tan, Ying Han, Yihong Chen, Xiangying Deng, Hong Shen, Shan Zeng, Yinghui Peng, Changjing Cai

Subjects: Get full text